Utilization of a Human Lung Tissue Resource for Vascular Research (R03)

Post Date

October 12th 2010

Application Due Date

October 14th 2011

Funding Opportunity Number

RFA-HL-11-032

CFDA Number(s)

93.838

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $1500000

• Award Range:

  $None - $None

Grant Description

This funding opportunity announcement (FOA) solicits research grant applications from organizations that propose to conduct human tissue- and cell-based vascular research. The primary goal of this initiative is to promote research that will advance translational efforts in lung vascular disease. This program makes available human biospecimens collected by the Pulmonary Hypertension Breakthrough Initiative (PHBI). Biospecimens may be used to investigate mechanistic research questions in lung vascular biology, including validating hypotheses of pulmonary arterial hypertension (PAH) pathogenesis. Innovative use of biospecimens for addressing general vascular biology research questions is encouraged.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-11-032.html